Reinhold U - Search Results

1

Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival.

Ugurel S, Rappl G, Tilgen W, Reinhold U. Ugurel S, et al. Among authors: reinhold u. J Clin Oncol. 2001 Jan 15;19(2):577-83. doi: 10.1200/JCO.2001.19.2.577. J Clin Oncol. 2001. PMID: 11208853

2

Chemosensitivity testing in malignant melanoma.

Ugurel S, Tilgen W, Reinhold U. Ugurel S, et al. Among authors: reinhold u. Recent Results Cancer Res. 2003;161:81-92. doi: 10.1007/978-3-642-19022-3_8. Recent Results Cancer Res. 2003. PMID: 12528801

3

Facts and pitfalls in the detection of tyrosinase mRNA in the blood of melanoma patients by RT-PCR.

Seiter S, Rappl G, Tilgen W, Ugurel S, Reinhold U. Seiter S, et al. Among authors: reinhold u. Recent Results Cancer Res. 2001;158:105-12. doi: 10.1007/978-3-642-59537-0_10. Recent Results Cancer Res. 2001. PMID: 11092037

4

Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma.

Hasselmann DO, Rappl G, Rössler M, Ugurel S, Tilgen W, Reinhold U. Hasselmann DO, et al. Among authors: reinhold u. Oncol Rep. 2001 Jan-Feb;8(1):115-8. doi: 10.3892/or.8.1.115. Oncol Rep. 2001. PMID: 11115581

5

Interlaboratory evaluation of a new reverse transcriptase polymerase chain reaction-based enzyme-linked immunosorbent assay for the detection of circulating melanoma cells: a multicenter study of the Dermatologic Cooperative Oncology Group.

Reinhold U, Berkin C, Bosserhoff AK, Deutschmann A, Garbe C, Gläser R, Hein R, Krähn G, Peter RU, Rappl G, Schittek B, Seiter S, Ugurel S, Volkenandt M, Tilgen W. Reinhold U, et al. J Clin Oncol. 2001 Mar 15;19(6):1723-7. doi: 10.1200/JCO.2001.19.6.1723. J Clin Oncol. 2001. PMID: 11251002

6

Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients.

Ugurel S, Rappl G, Tilgen W, Reinhold U. Ugurel S, et al. Among authors: reinhold u. Clin Cancer Res. 2001 May;7(5):1282-6. Clin Cancer Res. 2001. PMID: 11350895

7

Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.

Ugurel S, Rebmann V, Ferrone S, Tilgen W, Grosse-Wilde H, Reinhold U. Ugurel S, et al. Among authors: reinhold u. Cancer. 2001 Jul 15;92(2):369-76. doi: 10.1002/1097-0142(20010715)92:2<369::aid-cncr1332>3.0.co;2-u. Cancer. 2001. PMID: 11466692

8

Detection of tumor-associated circulating mRNA in patients with disseminated malignant melanoma.

Rappl G, Hasselmann DO, Rössler M, Ugurel S, Tilgen W, Reinhold U. Rappl G, et al. Among authors: reinhold u. Ann N Y Acad Sci. 2001 Sep;945:189-91. Ann N Y Acad Sci. 2001. PMID: 11708477

9

Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma.

Pföhler C, Haus A, Palmowski A, Ugurel S, Ruprecht KW, Thirkill CE, Tilgen W, Reinhold U. Pföhler C, et al. Among authors: reinhold u. Br J Dermatol. 2003 Jul;149(1):74-8. doi: 10.1046/j.1365-2133.2003.05377.x. Br J Dermatol. 2003. PMID: 12890197

10

Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients.

Rebmann V, Ugurel S, Tilgen W, Reinhold U, Grosse-Wilde H. Rebmann V, et al. Among authors: reinhold u. Int J Cancer. 2002 Aug 10;100(5):580-5. doi: 10.1002/ijc.10524. Int J Cancer. 2002. PMID: 12124808 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page